In papillary thyroid cancer, IGF2BP2 enhances the translation efficacy of erb-b2 receptor tyrosine kinase 2 (ERBB2) by binding to m6A motifs in its CDS, acquiring resistance to tyrosine kinase inhibitors 114. The gene discussed is IGF2BP2; the disease is thyroid gland papillary carcinoma.